13D/13G Filings - Novalis LifeSciences Investments II L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-06
4:05 pm
Purchase
2024-11-0413DTelesis Bio, Inc.
TBIO
Novalis LifeSciences Investments II L.P.442,959
19.990%
22,524increase
(+5.36%)
Filing
History
2024-07-18
5:32 pm
Unchanged
2024-07-1613DTelesis Bio, Inc.
TBIO
Novalis LifeSciences Investments II L.P.420,435
19.990%
0
(Unchanged)
Filing
History
2024-06-10
8:30 pm
Purchase
2024-06-0613DTelesis Bio, Inc.
TBIO
Novalis LifeSciences Investments II L.P.420,435
19.990%
8,214increase
(+1.99%)
Filing
History
2023-06-15
4:17 pm
Purchase
2023-06-0513DTelesis Bio, Inc.
TBIO
Novalis LifeSciences Investments II L.P.412,221
19.990%
412,221increase
(New Position)
Filing
History